First-line treatment with bevacizumab plus capecitabine for elderly patients with metastatic colorectal cancer: BECA trial

被引：0
|
作者：
Feliu, J.
Salut, A.
Safont, M.
Losa, F.
Garcia, C.
Bosch, C.
Escudero, P.
Lopez, R.
Bolanos, M.
Gonzalez-Baron, M.
机构：
[1] Hosp La Paz, Madrid, Spain
[2] Hosp Arnau Vilanova, Lleida, Spain
[3] Gen Hosp, Valencia, Spain
[4] Hosp Creu Roja, Lhospitalet De Llobregat, Spain
[5] Hosp Gen Yague, Burgos, Spain
[6] Hosp Dr Peset, Valencia, Spain
[7] Hosp Lozano Blesa, Zaragoza, Spain
[8] Hosp Clin, Santiago De Compostela, Spain
[9] Hosp San Pedro de Alcantara, Caceres, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15120
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    J Feliu
    M J Safont
    A Salud
    F Losa
    C García-Girón
    C Bosch
    P Escudero
    R López
    C Madroñal
    M Bolaños
    M Gil
    A Llombart
    J Castro-Carpeño
    M González-Barón
    [J]. British Journal of Cancer, 2010, 102 : 1468 - 1473
  • [2] Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    Feliu, J.
    Safont, M. J.
    Salud, A.
    Losa, F.
    Garcia-Giron, C.
    Bosch, C.
    Escudero, P.
    Lopez, R.
    Madronal, C.
    Bolanos, M.
    Gil, M.
    Llombart, A.
    Castro-Carpeno, J.
    Gonzalez-Baron, M.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 102 (10) : 1468 - 1473
  • [3] Reply: Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    J Feliu
    J Barriuso
    [J]. British Journal of Cancer, 2011, 104 : 226 - 226
  • [4] Comment on ‘Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer’
    M J Molina-Garrido
    C Guillén-Ponce
    [J]. British Journal of Cancer, 2011, 104 : 224 - 225
  • [5] Comment on 'Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer'
    Molina-Garrido, M. J.
    Guillen-Ponce, C.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 104 (01) : 224 - 225
  • [6] Reply: Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    Feliu, J.
    Barriuso, J.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 104 (01) : 226 - 226
  • [7] The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients
    Ozcelik, M.
    Odabas, H.
    Ercelep, O.
    Yuksel, S.
    Mert, A. G.
    Aydin, D.
    Surmeli, H.
    Isik, D.
    Isik, S.
    Oyman, A.
    Ustaalioglu, B. B. Oven
    Aliustaoglu, M.
    Gumus, M.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (06): : 617 - 624
  • [8] The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients
    M. Ozcelik
    H. Odabas
    O. Ercelep
    S. Yuksel
    A. G. Mert
    D. Aydin
    H. Surmeli
    D. Isik
    S. Isik
    A. Oyman
    B. B. Oven Ustaalioglu
    M. Aliustaoglu
    M. Gumus
    [J]. Clinical and Translational Oncology, 2016, 18 : 617 - 624
  • [9] Phase II study of bevacizumab in combination with capecitabine as first-line treatment in elderly patients with metastatic colorectal cancer
    Vrdoljak, Eduard
    Omrcen, Tomislav
    Boban, Marijo
    Hrabar, Andina
    [J]. ANTI-CANCER DRUGS, 2011, 22 (02) : 191 - 197
  • [10] Capecitabine Plus Bevacizumab as First-Line Therapy for Patients with Metastatic Colorectal Cancer and Poor Performance Status
    Yamada, Yasufumi
    Yoshimatsu, Kazuhiko
    Yokomizo, Hajime
    Okayama, Sachiyo
    Satake, Masaya
    Ida, Arika
    Maeda, Hiroyuki
    Shiozawa, Shunichi
    [J]. JOURNAL OF NIPPON MEDICAL SCHOOL, 2021, 88 (05) : 496 - 499
12345